Skip to content
Alivexis, Inc.
Unveiling the Future of Medicine
Menu
Home
Science
Pipeline
About Us
News
Public Notice
Contact Us
日本語
News
News
Modulus Discovery Establishes Wholly Owned U.S. Subsidiary and R&D Office in Cambridge, MA
- 15 December, 2017
Modulus Discovery Announces the Appointment of Koji Tsuda As Scientific Advisor
- 11 October, 2017
Modulus Discovery Announces the Appointment of Yutaka Akiyama as Scientific Advisor
- 01 October, 2017
Modulus Discovery Receives Amazon Web Services AWS Activate Program and Google Cloud Startup Awards
- 09 September, 2017
Modulus Discovery Announces Appointment of Osamu Nureki As Scientific Advisor
- 01 August, 2017
PeptiDream Signs Strategic Discovery Collaboration Agreement with Modulus Discovery, Inc.,
- 20 June, 2017
Modulus Discovery Announces the Appointment of Taka Koda, as Vice President, Corporate Planning
- 01 May, 2017
Previous
Press & Media Contact
Email address protected by JavaScript.
Please enable JavaScript to contact me.
Latest Release
Alivexis to Present at ACS Spring Conference
Alivexis Announces Notice of U.S. Patent Registration for Novel Cathepsin C Inhibitor
Alivexis and OHARA Pharmaceutical Co., Ltd. to Collaborate on Selected Drug Targets
Alivexis Announces Receipt of Intention to Exercise Option Right from Astellas Pharma Inc. for Collaboration on Novel Drug Target
Notice of Selection for the Ministry of Economy, Trade and Industry’s Domestic Generative AI Development Strengthening Project “GENIAC”
